American Healthcare Reit, Inc. (AHR) Technical Analysis
$44.55▲1.04%
Market is closed - opens 7 PM, 30 Oct 2025
Insights
- American Healthcare Reit is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for American Healthcare Reit stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, American Healthcare Reit stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for American Healthcare Reit stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 62.7 | Sell |
Stochastic | 81.8, 89.03 | Sell |
Ultimate Oscillator | 56.5 | Neutral |
Stochastic Relative Strength Index | 96.29, 94.02 | Neutral |
Moving Average Convergence Divergence | 0.62, 0.35 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.34 | Buy |
20 | 42.19 | Sell |
50 | 42.3 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.32 | Buy |
20 | 42.74 | Buy |
50 | 41.81 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 43.22 | Neutral |
20 | 42.13 | Buy |
50 | 42.28 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 44.13 | Buy |
20 | 43.46 | Buy |
50 | 43.36 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 44.45 | Buy |
20 | 43.87 | Buy |
50 | 43.28 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 45.66 |
Resistance L2 | 45.24 |
Resistance L1 | 44.81 |
Pivot Point | 44.39 |
Support L1 | 43.96 |
Support L2 | 43.54 |
Support L3 | 43.11 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.